These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 36094343)
21. Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice. Ren Z; Yang N; Ji C; Zheng J; Wang T; Liu Y; Zuo P Neuropharmacology; 2015 Jun; 93():209-18. PubMed ID: 25680233 [TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effects of ginkgetin against neuroinjury in Parkinson's disease model induced by MPTP via chelating iron. Wang YQ; Wang MY; Fu XR; Peng-Yu ; Gao GF; Fan YM; Duan XL; Zhao BL; Chang YZ; Shi ZH Free Radic Res; 2015; 49(9):1069-80. PubMed ID: 25968939 [TBL] [Abstract][Full Text] [Related]
23. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway. Hsu HT; Yang YL; Chang WH; Fang WY; Huang SH; Chou SH; Lo YC Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625589 [TBL] [Abstract][Full Text] [Related]
24. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway. Zhai A; Zhu X; Wang X; Chen R; Wang H Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112 [TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress. Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450 [TBL] [Abstract][Full Text] [Related]
26. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Price DA; Martinez AA; Seillier A; Koek W; Acosta Y; Fernandez E; Strong R; Lutz B; Marsicano G; Roberts JL; Giuffrida A Eur J Neurosci; 2009 Jun; 29(11):2177-86. PubMed ID: 19490092 [TBL] [Abstract][Full Text] [Related]
27. Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model. Tasaki Y; Yamamoto J; Omura T; Sakaguchi T; Kimura N; Ohtaki K; Ono T; Suno M; Asari M; Ohkubo T; Noda T; Awaya T; Shimizu K; Matsubara K Neurosci Lett; 2012 Jul; 521(1):15-9. PubMed ID: 22617635 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of transcription factor SP1 produces neuroprotective effects through decreasing MAO B activity in MPTP/MPP Yao L; Dai X; Sun Y; Wang Y; Yang Q; Chen X; Liu Y; Zhang L; Xie W; Liu J J Neurosci Res; 2018 Oct; 96(10):1663-1676. PubMed ID: 30004136 [TBL] [Abstract][Full Text] [Related]
29. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy. Zhu J; Dou S; Jiang Y; Chen J; Wang C; Cheng B Brain Res; 2019 Jul; 1715():203-212. PubMed ID: 30914252 [TBL] [Abstract][Full Text] [Related]
30. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease. Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118 [TBL] [Abstract][Full Text] [Related]
31. Ndfip1 protected dopaminergic neurons via regulating mitochondrial function and ferroptosis in Parkinson's disease. Fu X; Qu L; Xu H; Xie J Exp Neurol; 2024 May; 375():114724. PubMed ID: 38365133 [TBL] [Abstract][Full Text] [Related]
32. N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP Luo D; Zhao J; Cheng Y; Lee SM; Rong J Mol Neurobiol; 2018 Mar; 55(3):2258-2267. PubMed ID: 28321769 [TBL] [Abstract][Full Text] [Related]
33. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease. Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482 [TBL] [Abstract][Full Text] [Related]
34. The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection. Singh S; Singh K; Patel DK; Singh C; Nath C; Singh VK; Singh RK; Singh MP Rejuvenation Res; 2009 Jun; 12(3):185-97. PubMed ID: 19594327 [TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817 [TBL] [Abstract][Full Text] [Related]
36. Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress. You LH; Li Z; Duan XL; Zhao BL; Chang YZ; Shi ZH Brain Res; 2016 Jul; 1642():33-42. PubMed ID: 27017962 [TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system. Guo Z; Xu S; Du N; Liu J; Huang Y; Han M Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716 [TBL] [Abstract][Full Text] [Related]
38. Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Singh A; Verma P; Balaji G; Samantaray S; Mohanakumar KP Neurochem Int; 2016 Oct; 99():221-232. PubMed ID: 27395789 [TBL] [Abstract][Full Text] [Related]
39. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease. Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146 [TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model. Yang W; Chen YH; Liu H; Qu HD Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]